Liposeuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

Liposeuticals General Information

Description

Developer of sterile injectable drugs designed to treat anesthesiology, oncology, and infectious diseases. The company's drugs specialize in non-water-soluble that is based on a patented, non-toxic, drug reformulation technology platform, which utilizes pure sugar-lipid polymers that can solubilize compounds and disperse them, enabling healthcare practitioners to reduce drug wastage through vial reuse and enhance stability, reduce costs via extended shelf-life and eliminate antibiotic resistance and toxic recipients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 11 Deer Park Drive
  • Suite 121
  • Monmouth Junction, NJ 08852
  • United States
+1 (609)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 11 Deer Park Drive
  • Suite 121
  • Monmouth Junction, NJ 08852
  • United States
+1 (609)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Liposeuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jul-2025 Completed Generating Revenue
2. Later Stage VC (Series A) 03-Mar-2017 Completed Generating Revenue
1. Grant 01-Jan-2017 $150K Completed Generating Revenue
To view Liposeuticals’s complete valuation and funding history, request access »

Liposeuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Liposeuticals’s complete cap table history, request access »

Liposeuticals Patents

Liposeuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10064954-B2 Polymer-cyclodextrin-lipid conjugates Active 23-Jun-2015
US-20160375150-A1 Polymer-cyclodextrin-lipid conjugates Active 23-Jun-2015
US-10835608-B2 Polymer-carbohydrate conjugates for drug delivery technology Active 05-Dec-2013
US-20150157721-A1 Polymer-carbohydrate conjugates for drug delivery technology Active 05-Dec-2013
US-20130004592-A1 Pharmaceutical compositions for parenteral administration Active 28-Jun-2011 A61K47/26
To view Liposeuticals’s complete patent history, request access »

Liposeuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Liposeuticals FAQs

  • When was Liposeuticals founded?

    Liposeuticals was founded in 2011.

  • Where is Liposeuticals headquartered?

    Liposeuticals is headquartered in Monmouth Junction, NJ.

  • What is the size of Liposeuticals?

    Liposeuticals has 4 total employees.

  • What industry is Liposeuticals in?

    Liposeuticals’s primary industry is Drug Discovery.

  • Is Liposeuticals a private or public company?

    Liposeuticals is a Private company.

  • What is Liposeuticals’s current revenue?

    The current revenue for Liposeuticals is .

  • How much funding has Liposeuticals raised over time?

    Liposeuticals has raised $10M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process